Rational design and engineering of delivery systems for therapeutics: Biomedical exercises in colloid and surface science

Advances in Colloid and Interface Science

Volumn 106, Issue 1-3, 2003, Pages 147-168

  Kostarelos, Kostas ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Colloid delivery systems; Drug delivery; Gene therapy; Liposome; Radiotherapy

Indexed keywords

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; GENES; INTERFACES (MATERIALS); PHARMACODYNAMICS; RADIOTHERAPY; SURFACE CHEMISTRY;

COLLOID DELIVERY SYSTEMS; GENE THERAPY; LIPOSOMES; THERAPEUTIC AGENTS;

COLLOID CHEMISTRY;

DRUG; DRUG CARRIER; LIPOSOME;

BIOMEDICAL ENGINEERING; CHEMISTRY; COLLOID; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG THERAPY; GENE TRANSFER; INSTRUMENTATION; METHODOLOGY; PHARMACEUTICS; REVIEW; SURFACE PROPERTY; SYNTHESIS;

BIOMEDICAL ENGINEERING; COLLOIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG THERAPY; GENE TRANSFER TECHNIQUES; LIPOSOMES; PHARMACEUTICAL PREPARATIONS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 0345171415     PISSN: 00018686     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-8686(03)00109-X     Document Type: Article

References (118)

1. Langer R. Science. 293:2001;58.
2. Langer R. Sci. Am. 288:2003;50.
3. LaVan D.A., Lynn D.M., Langer R. Nat. Rev. Drug Discov. 1:2002;77.
4. Malmsten M. Surfactants and Polymers in Drug Delivery. 2002;Marcel Dekker, New York.
5. Burgess D.J. Swarbrick J., Boylan J.C. Encyclopedia of Pharmaceutical Technology. 2002;Marcel Dekker, New York and Basel.
6. Grahame-Smith D.G. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 2002;Oxford University Press, Oxford.
7. Boroujerdi M. Pharmacokinetics: Principles and Applications. 2002;McGraw-Hill, New York and London.
8. Saltzman W.M. Drug Delivery: Engineering Principles for Drug Therapy. 2001;Oxford University Press, Oxford.
9. Goren D., Gabizon A. Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. 1998;Elsevier Science, Amsterdam.
10. Krishna R., Webb M.S., Onge G.St., Mayer L.D. J. Pharmacol. Exp. Ther. 298:2001;1206.
11. Langer R. Nature. 392:1998;5.
12. Torchilin V.P. Eur. J. Pharm. Sci. 11:(Suppl 2):2000;S81.
13. Yuan F., Krol A., Tong S. Ann. Biomed. Eng. 29:2001;1150.
14. Dellian M., Yuan F., Trubetskoy V.S., Torchilin V.P., Jain R.K. Br. J. Cancer. 82:2000;1513.
15. Blau S., Jubeh T.T., Haupt S.M., Rubinstein A. Crit. Rev. Ther. Drug Carrier Syst. 17:2000;425.
16. Allen T.M. Nat. Rev. Cancer. 2:2002;750.
17. Moghimi S.M., Hunter A.C., Murray J.C. Pharmacol. Rev. 53:2001;283.
18. Seymour L.W. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;135.
19. Harris J.M., Chess R.B. Nat. Rev. Drug Discov. 2:2003;214.
20. Hafez I.M., Cullis P.R. Adv. Drug Deliv. Rev. 47:2001;139.
21. Qiu Y., Park K. Adv. Drug Deliv. Rev. 53:2001;321.
22. Kono K. Adv. Drug Deliv. Rev. 53:2001;307.
23. Needham D., Anyarambhatla G., Kong G., Dewhirst M.W. Cancer Res. 60:2000;1197.
24. Shum P., Kim J.M., Thompson D.H. Adv. Drug Deliv. Rev. 53:2001;273.
25. Spratt T., Bondurant B., O'Brien D.F. Biochim. Biophys. Acta. 1611:2003;35.
26. Price R.J., Kaul S. J. Cardiovasc. Pharmacol. Ther. 7:2002;171.
27. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., , et al. Cancer Res. 60:2000;6641.
28. Plank C., Scherer F., Schillinger U., Bergemann C., Anton M. J. Liposome Res. 13:2003;29.
29. Hyde S.C., Southern K.W., Gileadi U., Fitzjohn E.M., Mofford K.A., Waddell B.E., , et al. Gene Ther. 7:2000;1156.
30. Barron L.G., Uyechi L.S., Szoka F.C. Jr. Gene Ther. 6:1999;1179.
31. Marshall J., Nietupski J.B., Lee E.R., Siegel C.S., Rafter P.W., Rudginsky S.A., , et al. J. Drug Target. 7:2000;453.
32. Gabizon A., Martin F. Drugs. 54:(Suppl 4):1997;15.
33. Gabizon A., Shmeeda H., Barenholz Y. Clin. Pharmacokinet. 42:2003;419.
34. Burczynski F.J., Wang G.Q., Hnatowich M. Br. J. Pharmacol. 120:1997;1215.
35. Kamps J.A., Scherphof G.L. Adv. Drug Deliv. Rev. 32:1998;81.
36. Bell P.C., Bergsma M., Dolbnya I.P., Bras W., Stuart M.C., Rowan A.E., , et al. J. Am. Chem. Soc. 125:2003;1551.
37. Zuhorn I.S., Oberle V., Visser W.H., Engberts J.B., Bakowsky U., Polushkin E., , et al. Biophys. J. 83:2002;2096.
38. Nagayasu A., Uchiyama K., Kiwada H. Adv. Drug Deliv. Rev. 40:1999;75.
39. Liu F., Liu D. Pharm. Res. 12:1995;1060.
40. Ogawara K., Furumoto K., Takakura Y., Hashida M., Higaki K., Kimura T. J. Control Release. 77:2001;191.
41. Hardman J.G., Hardman J.G., Limbird L.E., Goodman Gilman A. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 2001;McGraw-Hill Professional.
42. Pollack G.H. Adv. Colloid Interface Sci. 103:2003;173.
43. Saltzman W.M. Drug Delivery: Engineering Principles for Drug Therapy. 2001;Oxford University Press, Oxford.
44. van de Waterbeemd H., Gifford E. Nat. Rev. Drug Discov. 2:2003;192.
45. Ledley T.S., Ledley F.D. Hum. Gene Ther. 5:1994;679.
46. Hu Q., Bally M.B., Madden T.D. Nucl. Acids Res. 30:2002;3632.
47. Adlakha-Hutcheon G., Bally M.B., Shew C.R., Madden T.D. Nat. Biotechnol. 17:1999;775.
48. Richardson T.P., Murphy W.L., Mooney D.J. Crit. Rev. Eukaryot. Gene Expr. 11:2001;47.
49. Kim T.K., Burgess D.J. J. Pharm. Pharmacol. 54:2002;897.
50. Saltzman W.M., Mak M.W., Mahoney M.J., Duenas E.T., Cleland J.L. Pharm. Res. 16:1999;232.
51. Brigger I., Morizet J., Aubert G., Chacun H., Terrier-Lacombe M.J., Couvreur P., , et al. J. Pharmacol. Exp. Ther. 303:2002;928.
52. Muller R.H., Benita S., Bohm B.H.L. Emulsions and Nanosuspensions for the Formulation of Poorly Soluble Drugs. 1998;Scientific Publishers, Stuttgart. Medpharm.
53. Garti N., Aserin A. Benita S. Microencapsulation, Methods and Industrial Applications. 1996;411 Marcel Dekker, New York.
54. Kreilgaard M. Adv. Drug Deliv. Rev. 54:(Suppl 1):2002;S77.
55. Duncan R. Nat. Rev. Drug Discov. 2:2003;347.
56. Pileni M.P. Nat. Mater. 2:2003;145.
57. Lee K.Y., Mooney D.J. Chem. Rev. 101:2001;1869.
58. Wise D.L., Brannon-Peppas L., Klibanov A.M., Langer R.L., Mikos A.G., Peppas N.A., Trantolo D.J., Wnek G.E., Yaszemski M.J. Handbook of Pharmaceutical Controlled Release Technology. 2000;Marcel Dekker, New York.
59. Faraasen S., Voros J., Csucs G., Textor M., Merkle H.P., Walter E. Pharm. Res. 20:2003;237.
60. Eyles J.E., Bramwell V.W., Williamson E.D., Alpar H.O. Vaccine. 19:2001;4732.
61. Zauner W., Farrow N.A., Haines A.M. J. Control Release. 71:2001;39.
62. Teixeira H., Dubernet C., Chacun H., Rabinovich L., Boutet V., Deverre J.R., , et al. J. Control Release. 89:2003;473.
63. Benita S. Submicron Emulsion in Drug Targeting and Delivery. 1998;Harwood Academic Publishers, Amsterdam.
64. Bagwe R.P., Kanicky J.R., Palla B.J., Patanjali P.K., Shah D.O. Crit. Rev. Ther. Drug Carrier Syst. 18:2001;77.
65. Crommelin D.J., Storm G. J. Liposome Res. 13:2003;33.
66. Lasic D.D., Papahadjopoulos D. Medical Applications of Liposomes. 1998;Elsevier Health Sciences, Amsterdam.
67. Kabanov A.V., Batrakova E.V., Miller D.W. Adv. Drug Deliv. Rev. 55:2003;151.
68. Kabanov A.V., Lemieux P., Vinogradov S., Alakhov V. Adv. Drug Deliv. Rev. 54:2002;223.
69. Torchilin V.P., Lukyanov A.N., Gao Z., Papahadjopoulos-Sternberg B. Proc. Nat. Acad. Sci. USA. 100:2003;6039.
70. Savic R., Luo L., Eisenberg A., Maysinger D. Science. 300:2003;615.
71. Muller R.H., Radtke M., Wissing S.A. Adv. Drug Deliv. Rev. 54:(Suppl 1):2002;S131.
72. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., , et al. J. Am. Chem. Soc. 125:2003;7860.
73. Couvreur P., Barratt G., Fattal E., Legrand P., Vauthier C. Crit. Rev. Ther. Drug Carrier Syst. 19:2002;99.
74. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., , et al. Gene Ther. 9:2002;102.
75. Larson D.R., Zipfel W.R., Williams R.M., Clark S.W., Bruchez M.P., Wise F.W., , et al. Science. 300:2003;1434.
76. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., , et al. J. Am. Chem. Soc. 125:2003;4451.
77. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. Science. 298:2002;1759.
78. Akerman M.E., Chan W.C., Laakkonen P., Bhatia S.N., Ruoslahti E. Proc. Nat. Acad. Sci. USA. 99:2002;12617.
79. Woodle M.C., Scaria P. Curr. Opin. Coll. Int. Sci. 6:2001;78.
80. Verma I.M. Mol. Ther. 6:2002;565.
81. Gregoriadis G., Ryman B.E. Biochem. J. 124:1971;58p.
82. Abra R.M., Hunt C.A. Biochim. Biophys. Acta. 666:1981;493.
83. Gabizon A., Papahadjopoulos D. Biochim. Biophys. Acta. 1103:1992;94.
84. Takakura Y., Nishikawa M., Yamashita F., Hashida M. J. Drug Target. 10:2002;99.
85. Huang S.K., Mayhew E., Gilani S., Lasic D.D., Martin F.J., Papahadjopoulos D. Cancer Res. 52:1992;6774.
86. James N.D., Coker R.J., Tomlinson D., Harris J.R., Gompels M., Pinching A.J., , et al. Clin. Oncol. (R Coll. Radiol.). 6:1994;294.
87. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. FEBS Lett. 268:1990;235.
88. Needham D., Kim D.H. Colloids Surf. B Biointerfaces. 18:2000;183.
89. Torchilin V.P., Omelyanenko V.G., Papisov M.I., Bogdanov A.A. Jr, Trubetskoy V.S., Herron J.N., , et al. Biochim. Biophys. Acta. 1195:1994;11.
90. Woodle M.C., Lasic D.D. Biochim. Biophys. Acta. 1113:1992;171.
91. Moreira J.N., Gaspar R., Allen T.M. Biochim. Biophys. Acta. 1515:2001;167.
92. Boerman O.C., Oyen W.J., Storm G., Corvo M.L., van Bloois L., van der Meer J.W., , et al. Ann. Rheum Dis. 56:1997;369.
93. Laverman P., Dams E.T., Storm G., Hafmans T.G., Croes H.J., Oyen W.J., , et al. J. Control Release. 75:2001;347.
94. Gabizon A., Goren D., Cohen R., Barenholz Y. J. Control Release. 53:1998;275.
95. K. Kostarelos, unpublished data.
96. Woodle M.C., Newman M.S., Martin F.J. Int. J. Pharm. 88:1992;327.
97. Kostarelos K., Tadros T.F., Luckham P.F. Langmuir. 15:1999;369.
98. Patel H.M., Moghimi S.M. Adv. Drug Deliv. Rev. 32:1998;45.
99. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Pharmacol. Rev. 51:1999;691.
100. Bradley A.J., Devine D.V. Adv. Drug Deliv. Rev. 32:1998;19.
101. Smyth Templeton N., Lasic D.D. Gene Therapy: Therapeutic Mechanisms and Strategies. 2000;Marcel Dekker, New York.
102. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., , et al. Science. 275:1997;1320.
103. Nemerow G.R., Stewart P.L. Microbiol. Mol. Biol. Rev. 63:1999;725.
104. Stewart P.L., Burnett R.M., Cyrklaff M., Fuller S.D. Cell. 67:1991;145.
105. Krasnykh V., Dmitriev I., Navarro J.G., Belousova N., Kashentseva E., Xiang J., , et al. Cancer Res. 60:2000;6784.
106. Kovesdi I., Brough D.E., Bruder J.T., Wickham T.J. Curr. Opin. Biotechnol. 8:1997;583.
107. K. Kostarelos, R. Singh, S. Worgall, R.G. Crystal, American Chemical Society Annual Meeting. ACS, San Francisco, CA, USA, 2000, p. 378.
108. Worgall S., Worgall T.S., Kostarelos K., Singh R., Leopold P.L., Hackett N.R., , et al. Mol. Ther. 1:2000;39.
109. Kostarelos K., Singh R., Hogan S., Deo N., Leopold P.L., Somasundaran P., , et al. Mol. Ther. 1:2000;S244.
110. Phillips W.T., Goins B. J. Liposome Res. 12:2002;71.
111. Torchilin V.P. Adv. Drug Deliv. Rev. 54:2002;235.
112. Presant C.A., Blayney D., Proffitt R.T., Turner A.F., Williams L.E., Nadel H.I., , et al. Lancet. 335:1990;1307.
113. Harrington K.J., Mohammadtaghi S., Uster P.S., Glass D., Peters A.M., Vile R.G., , et al. Clin. Cancer Res. 7:2001;243.
114. Laverman P., Boerman O.C., Oyen W.J., Dams E.T., Storm G., Corstens F.H. Adv. Drug Deliv. Rev. 37:1999;225.
115. Kostarelos K., Emfietzoglou D. J. Liposome Res. 9:1999;429.
116. Kostarelos K., Emfietzoglou D. Anticancer Res. 20:2000;3339.
117. Kostarelos K., Emfietzoglou D., Stamatelou M. J. Liposome Res. 9:1999;407.
118. Emfietzoglou D., Kostarelos K., Sgouros G. J. Nucl. Med. 42:2001;499.